NOX4 and cancer: Interestingly, tumoral NOX4 has also been shown to recruit M2 tumor-associated macrophages via ROS signaling to promote cancer growth, suggesting that NOX inhibitors could also have the potential to induce indirect anti-cancer effects by modulating the tumor immune microenvironment [25].